Clinical trial
CHANCE - Candesartan in Hypertrophic Cardiomyopathy
NCT00430833 · Charles University, Czech Republic, Other · Unknown status
Key facts
| NCT number | NCT00430833 |
|---|---|
| Title | CHANCE - Candesartan in Hypertrophic Cardiomyopathy |
| Official title | Candesartan Use in Hypertrophic and Non-Obstructive Cardiomyopathy Estate (The CHANCE): a Double-Blind, Placebo-Controlled, Randomized, Multicenter Study |
| Lead sponsor | Charles University, Czech Republic, Other |
| Collaborators | AstraZeneca Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertrophic Cardiomyopathy |
| Intervention type | Drug |
| Interventions | candesartan |
| First posted | Feb 2, 2007 |
| Last update posted | Feb 2, 2007 |
| Countries | Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: